吡唑并[1,5-a]嘧啶-3-甲酸，CAS 登记号 25940-35-6，由济南圣和化工有限公司现货供应，可提供纯度 按批次COA提供(不公开发布) 的规格，下游主要用于有机化学品。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。
有机化学品
每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。
本页已列出 吡唑并[1,5-a]嘧啶-3-甲酸 的 CAS 号：25940-35-6，可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布)，包装形式为 按订单/批次确认(不公开发布)，特殊规格可在询价时说明。
主要涉及有机化学品。
来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。
Pyrazolo[1,5-a]pyrimidine-3-carboxylic acid · CAS 25940-35-6 · C7H5N3O2. UNII Z283862198.
| CAS Registry Number | 25940-35-6 |
|---|---|
| PubChem CID | 1910189 |
| Molecular formula | C7H5N3O2 |
| IUPAC name | pyrazolo[1,5-a]pyrimidine-3-carboxylic acid |
| UNII (FDA) | Z283862198 |
| Molecular Weight | 163.13 |
|---|---|
| XLogP3 | -0.1 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 1 |
| Exact Mass | 163.038176411 |
| Monoisotopic Mass | 163.038176411 |
| Topological Polar Surface Area | 67.5 |
| Heavy Atom Count | 12 |
| Formal Charge | 0 |
| Reported hazard statements | H302 (88.9%), H315 (100%), H319 (100%), H335 (100%) |
|---|
H302 (88.9%): Harmful if swallowed [Warning Acute toxicity, oral]
H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]
Pyrazolo[1,5-a]pyrimidine-3-carboxylic acid; 25940-35-6; DTXSID70365572; Pyrazolo(1,5-a)pyrimidine-3-carboxylic acid; RefChem:376212; DTXCID40316612; 681-761-1; HNYVPKNVKSTVJO-UHFFFAOYSA-N; MFCD01975194; C7H5N3O2; Pyrazolo[1,5-a]pyrimidine-3-carboxylicacid; BAS 01516081; 3-Carboxypyrazolo[1,5-a]pyrimidine; SCHEMBL309036; F2192-0011; DS-2609
CAS 25940-35-6; molecular formula C7H5N3O2; molecular weight — g/mol.
Pyrazolo[1,5-a]pyrimidine-3-carboxylic acid, 25940-35-6, DTXSID70365572, Pyrazolo(1,5-a)pyrimidine-3-carboxylic acid, RefChem:376212, DTXCID40316612.
Hazard statements reported: H302, H315, H319, H335.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.